Holekamp’s prospective study included 17 eyes of 15 patients diagnosed with wet AMD, “but the beauty of this technology is that you can monitor both eyes,” she said.

Have end-stage AMD in both eyes, either wet or dry Have visual acuity of between 20/160 and 20/800 Have not had results from all other forms of AMD treatment ...

LumiThera’s PBM is the only device that has demonstrated meaningful vision improvement compared to baseline for people living ...

Age-related macular degeneration affects central vision. Simple home changes can help maintain independence. We'll cover safety improvements, lighting, colors, organization, and helpful devices ...

Alcon has inked a deal to acquire LumiThera and its light-based therapy for dry age-related macular degeneration, which ...

Fact checked by Nick Blackmer Meet the Expert Bryan Wolynski, OD, is a board-certified optometrist who has been in the field for over 30 years. He is an adjunct assistant clinical professor at the ...